Prospects for the therapy and prevention of dengue virus infections

被引：22

作者：

Damonte, EB ^{[1
]}

Pujol, CA ^{[1
]}

Coto, CE ^{[1
]}

机构：

[1] Univ Buenos Aires, Coll Exact & Nat Sci, Dept Biol Chem, Virol Lab, RA-1428 Buenos Aires, DF, Argentina

来源：

ADVANCES IN VIRUS RESEARCH, VOL. 63 | 2004年 / 63卷

关键词：

D O I：

10.1016/S0065-3527(04)63004-1

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

[No abstract available]

引用

页码：239 / 285

页数：47

共 214 条

[1]

Alvarez M, 2001, Int J Infect Dis, V5, P35, DOI 10.1016/S1201-9712(01)90046-3

[2] Development of a novel mouse model for dengue virus infection [J].

An, J ;

Kimura-Kuroda, J ;

Hirabayashi, Y ;

Yasui, K .

VIROLOGY, 1999, 263 (01) :70-77

[3] CORRELATION OF E-PROTEIN BINDING WITH CELL SUSCEPTIBILITY TO DENGUE-4 VIRUS-INFECTION [J].

ANDERSON, R ;

KING, AD ;

INNIS, BL .

JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2155-2159

[4]

Angsubhakorn Subhkij, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P554

[5]

Avirutnan P, 1998, J IMMUNOL, V161, P6338

[6] Recent advances in vaccines against viral haemorrhagic fevers [J].

Baize, S ;

Marianneau, P ;

Georges-Courbot, MC ;

Deubel, V .

CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (05) :513-518

[7]

Barrett ADT, 2001, ANN NY ACAD SCI, V951, P262

[8] USE OF A FLAVIVIRUS RNA-DEPENDENT RNA-POLYMERASE ASSAY TO INVESTIGATE THE ANTIVIRAL ACTIVITY OF SELECTED COMPOUNDS [J].

BARTHOLOMEUSZ, A ;

TOMLINSON, E ;

WRIGHT, PJ ;

BIRCH, C ;

LOCARNINI, S ;

WEIGOLD, H ;

MARCUCCIO, S ;

HOLAN, G .

ANTIVIRAL RESEARCH, 1994, 24 (04) :341-350

[9] DENGUE FEVER VIRUS AND JAPANESE ENCEPHALITIS-VIRUS SYNTHETIC PEPTIDES, WITH MOTIFS TO FIT HLA CLASS-I HAPLOTYPES PREVALENT IN HUMAN-POPULATIONS IN ENDEMIC REGIONS, CAN BE USED FOR APPLICATION TO SKIN LANGERHANS CELLS TO PRIME ANTIVIRAL CD8(+) CYTOTOXIC T-CELLS (CTLS) - A NOVEL-APPROACH TO THE PROTECTION OF HUMANS [J].

BECKER, Y .

VIRUS GENES, 1994, 9 (01) :33-45

[10] Live attenuated tetravalent dengue vaccine [J].

Bhamarapravati, N ;

Sutee, Y .

VACCINE, 2000, 18 :44-47

← 1 2 3 4 5 6 7 8 9 10 →